Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
Immix Biopharma closed a $150 million underwritten registered offering, selling 16,778,524 shares of common stock at a public price of $8.94 per share. Net proceeds to the company were approximately $140.65 million after deducting underwriting discounts and expenses. The financing was supported by leading U.S.
Key figures
- Offering Price
- 8.94
- Shares Offered
- 16778524
- Net proceeds
- $140.65 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.